IMMRAY Trademark
IMMRAY is a USPTO trademark filed by Immunovia AB. Status: Cancelled.
Trademark Facts
| Mark | IMMRAY |
|---|---|
| Serial Number | 79176421 |
| Registration Number | 5202108 |
| Status | Cancelled |
| Filing Date | 2015-08-24 |
| Registration Date | 2017-05-16 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 009 (Electronics & Software), 010 (Medical Devices), 042 (Software & IT), 044 (Medical Services) |
| Owner | Immunovia AB |
| Attorney of Record | Susan Neuberger Weller |
| Prosecution Events | 46 |
| Latest Event | DENA on 2026-03-19 |
Goods & Services
Computer software for diagnosis of disease; Computer software for diagnosing of cancer diseases; Computer software for diagnosing of pancreatic cancer; Computer software for diagnosing of breast cancer; Computer software for diagnosing of prostate cancer; Computer software for diagnosing of auto-immune diseases; DNA chips; Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseases; Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseases; Medical apparatus and instruments for diagnostic, prognostic patient stratification, examination and monitoring purposes, namely, apparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseases; Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing services, namely, computer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer software